Charles Dahl, MD

Principal investigator · Provo, Utah

← All Investigators

Charles Dahl, MD

Principal investigator

Clinical background and research leadership

Cardiology & lipid disorders

Dr. Dahl brings more than four decades of cardiology practice and longstanding cardiovascular research leadership to Boeson’s Provo site, where he has served as a principal investigator since 2024.

Clinical and research leadership: His career includes directing cardiology research at Utah Valley Regional Medical Center from 1985 to 2004, leading non-invasive cardiology and echocardiography services, and medical-director roles in clinical research at Revere Health and Aspen Clinical Research. He also has experience in medical education and cardiovascular quality review.

Research experience: His career PI work spans acute coronary syndromes, post-infarction ventricular dysfunction, cardiovascular outcomes, hypercholesterolemia and lipid-lowering therapies. His Boeson PI portfolio focuses on atherosclerotic cardiovascular disease and cardiovascular risk. This research background is complemented by clinical expertise in non-invasive cardiology and echocardiography.

Training: MD, University of Arizona Health Sciences Center; internal-medicine internship and residency, University of Utah affiliated hospitals; cardiology fellowship, University of Arizona Health Sciences Center.

Study fit: Select Dr. Dahl for deep cardiovascular trial experience, lipid expertise and experienced cardiology oversight across prevention and outcomes research.

Related research areas

Bring your next study to Boeson

Put this expertise to work on your next protocol. Share your study synopsis, target population and timeline to begin investigator and site selection with Boeson.

Request an investigator CV and relevant study experience to support your site-selection review.

Explore the local investigator team

Discuss a study with Boeson

Send your nonconfidential synopsis to start site selection with our team.

Investigator profile updated September 2026. Looking to participate? Explore study opportunities.